In ovarian cancer, CD39+PD-1+CD103+ Tregs exhibit an activated/exhausted tumor-resident phenotype associated with poor prognosis (29), and similar findings have been reported in papillary thyroid carcinoma (26). This evidence concerns the gene PDCD1 and differentiated thyroid carcinoma.